Literature DB >> 6615095

Comparative in vitro activities of third-generation cephalosporins.

R J Fass.   

Abstract

The in vitro susceptibilities of 823 clinical isolates to eight third-generation cephalosporin and cephalosporinlike antibiotics were studied. All eight antibiotics were more active and had broader spectrums of activity against gram-negative bacilli and anaerobes than older derivatives; however, they were less active against gram-positive cocci. Cefotaxime sodium, cefmenoxime hydrochloride, ceftriaxone disodium, and ceftizoxime sodium had similar activities. Cefoperazone sodium was more active than those drugs against Pseudomonas aeruginosa but less active against Enterobacteriaceae and Acinetobacter. Ceftazidime pentahydrate was more active against P aeruginosa but less active against gram-positive cocci. Moxalactam disodium was more active against some Enterobacteriaceae, Pseudomonas maltophilia, and Bacteroides fragilis but less active against gram-positive cocci. Thienamycin formamidide monohydrate had the broadest spectrum of activity and was the only antibiotic active against Streptococcus faecalis; the only resistant species were P maltophilia and Pseudomonas cepacia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6615095

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins.

Authors:  M L van Ogtrop; H F Guiot; H Mattie; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.

Authors:  K E Aldridge; H M Wexler; C V Sanders; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

3.  In vitro antibiotic sensitivity pattern of common bacterial isolates from cases of acute bacterial meningitis with special reference to ceftriaxone.

Authors:  B N Rao; I M Kashbur; N M Shembesh; S M el Bargathy
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

4.  A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.

Authors:  S Vartivarian; E Anaissie; G Bodey; H Sprigg; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

5.  The great cephalosporin wars.

Authors:  M S Cohen
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

Review 6.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

7.  Ceftriaxone levels in blood and tissue during cardiopulmonary bypass surgery.

Authors:  C S Bryan; S L Morgan; A B Jordan; C W Smith; J P Sutton; J D Gangemi
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 8.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

Review 9.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

10.  Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.

Authors:  S L Barriere; D C Ozasa; J Mordenti
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.